Eisai to transfer its global epilepsy drug manufacturing to UK
Eisai is to move all its global manufacturing of anti-epilepsy drug, Fycompa, to the UK – the first time the pharma company has manufactured a drug outside of Japan. Japanese pharmaceutical company, Eisai, has announced that its UK production facility has received its license…